CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in ...

MUNICH, Germany & ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (Nasdaq:CLRT) and Definiens, Inc. jointly announced today that they established a strategic partnership to employ a series of ...

MUNICH, GERMANY / ACCESSWIRE / September 10, 2018 / Definiens AG, the tissue phenomics company, focused on the development and application of tissue based biomedical digital image analysis, data ...

MUNICH, GERMANY / ACCESSWIRE / July 26, 2018 / Definiens AG, the leader in Tissue Phenomics® is very pleased to announce the appointment of Mr. Markus Schunk as Chief Operating Officer, a Management ...

Under the terms of the agreement, Definiens will train Tessella consultants to deploy and integrate Definiens image analysis technology into the IT infrastructures of large pharmaceutical and ...

Definiens, the number one Enterprise Image Intelligence™ company, has announced the introduction of a new multi-dimensional image analysis platform. Software applications built on Definiens XD extract ...

Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /CNW/ -- Definiens, a leading international ...

Wellington Partners, a leading pan-European venture capital firm, today announced that it acted as lead investor in a € 15 million growth financing round at Definiens AG, Munich, Germany. Wellington ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics ® solutions from biomarker discovery to meaningful ...

U.S. satellite navigation hardware manufacturer Trimble is acquiring Munich, Germany-based Definiens AG’s Earth sciences business assets and licensing its eCognition geospatial imaging analysis ...

"The core of this collaboration unites the power of Definiens' AI-based biomarker analysis and data science expertise with Targos' vast experience in tissue-based biomarker analysis and application in ...

The collaboration will provide a standardized and scalable solution to enable access to IF multiplex immunohistochemistry (IHC) assays. The joint offering will comprehensively address clinical ...